Capsida Biotherapeutics Presents New Data Validating Potential of Its Targeted, Non-invasive Gene Therapy Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
/PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), the only fully integrated gene therapy platform company that through intravenous (IV) delivery of a...
Source: prnewswire.com